 NASHVILLE, Tenn.--BUSINESS WIRE--- HROW--Harrow Health, Inc. NASDAQ: HROW, an ophthalmic-focused healthcare company, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in two upcoming virtual investor conferences. Harrow Health will participate in the H.C. Wainwright Ophthalmology Virtual Conference to be held August 17, 2021. The Companys pre-recorded presentation will be available via a link on the investor relations section of 